Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have blood test results showing signs of inflammation in the body (specific markers include CRP, IL-6, or a white blood cell ratio — the trial site can confirm what these mean for a specific case)
- People who are currently hospitalised mainly because their chronic heart failure has suddenly gotten worse (known as acute decompensated chronic systolic heart failure)
- People who are being considered as a possible candidate for a heart pump device called an LVAD, with a weakened heart pumping function confirmed by imaging, severe heart failure symptoms that have not improved with the best available medicines over at least 45 of the last 60 days, and a very limited ability to exercise or a need for a temporary heart support device or medicines given through a drip to keep the heart working
- People whose kidneys are functioning at a sufficient level, with a kidney function score (eGFR) of at least 40 within the past 90 days
- People who have either severe right-sided heart failure or worsening kidney function linked to their heart condition, with specific measurements taken through a heart catheter confirming this (the trial site can clarify the exact thresholds)
- People who already have a special heart monitoring catheter (called a PA catheter) in place at the time of joining the trial
- People with a specific heart pressure reading (pulmonary capillary wedge pressure) of at least 20 mmHg
Who may not be able to join:
- People who have a clear medical reason why an LVAD heart pump would not be suitable for them, and where that reason is unlikely to improve
- People who have had a previous allergic or sensitivity reaction to components used in dialysis equipment
- People who have an active bacterial infection in the bloodstream
- People with a high fever (38.6°C / 101.5°F or above), a high white blood cell count, or any suspected active infection throughout the body
- People with a cancer that has spread to other parts of the body and requires chemotherapy, biological therapy, or radiation treatment
- People who need certain strong blood pressure-raising medications given through a drip, or a particular heart stimulating medication above a specific dose (confirm exact medications and doses with the trial site)
- People who need a machine to help them breathe
- People who need nutrition delivered entirely through a drip into a vein during the treatment period
- People with persistently very low blood pressure (systolic blood pressure below 80 mmHg)
- People with a low white blood cell count below a certain threshold
- People with a low platelet count below a certain threshold
- People with very poor kidney function (creatinine above 4 mg/dL) or who are already receiving dialysis or continuous kidney replacement therapy
- People who have had a heart attack or acute coronary event within the past month
- People who are pregnant, breastfeeding, or actively trying to become pregnant
- People who are already participating in another clinical trial that involves a test drug or device
- People who have used any other experimental drug or device within the past 30 days (participation in studies involving only measurements or sample collection is generally permitted — confirm with the trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Need for continuous IV vasopressor support; Acute myocardial infarction; Mortality; Percentage of subjects with reversal of WRF and increase eGFR and PCW; Percentage of subjects who no longer have severe right ventricular failure; Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.